ECE2022 Eposter Presentations Reproductive and Developmental Endocrinology (93 abstracts)
PCOS SEVa: High prevalence anxiety and body dysmorphia in women with PCOS attending specialist care in the UK and India
Meghnaa Hebbar 1 , Salomi Shaikh 2 , Nawal Zia 1 , Jameela Sheikh 1 , Saskia Wicks 3 , Sindoora Jayaprakash 4 , Alisha Narendran 5 , Halimah Khalil 1 , Helena Gleeson 6 , Lynne Robinson 7 , Justin J. Ch 7 , Tejal Lathia 8 , Chitra Selvan 9 , Wiebke Arlt 6 , 10 & Punith Kempegowda 6,10
1College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; 2Padmashree D.Y, Patil School of Medicine, Navi Mumbai, Mumbai, India; 3Barts Health NHS Trust, London, United Kingdom; 4The Dudley Group NHS Foundation Trust, Dudley, United Kingdom; 5King Edward VI High School for Girls, Birmingham, Birmingham, United Kingdom; 6Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; 7Birmingham Women’s Hospital, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom; 8Apollo Hospitals, Navi Mumbai, Mumbai, India; 9Department of Endocrinology, MS Ramaiah Medical College, Bengaluru, Bangalore, India; 10Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom
Introduction: National Institute of Health and Care Excellence (NICE) recommends screening for emotional wellbeing as part of consultations for polycystic ovary syndrome (PCOS).
Aim: We evaluated several dimensions of emotional wellbeing in people attending PCOS consultation with specialists in the UK and India.
Methods: All people attending specialist clinics in a tertiary centre in the UK from October 2020 to September 2021 and in India between March 2021 to September 2021 were invited to complete a survey before and after attending the clinic. This survey had questions on demographics, Hospital Anxiety and Depression Scale (score 8-10 borderline; score ≥11 cases of anxiety and depression, respectively), Body Image Concern Inventory (BICI; score ≥72 suggestive of body dysmorphic disorder, BDD), Beliefs About Obese Persons Scale (BAOP; higher score suggestive of weight bias), and Female Sexual Function Index (FSFI; higher score suggestive of psychosexual dysfunction).
Results: A total of 115 women (36 UK and 79 India) completed the survey. The prevalence of anxiety and depression were 56.5% (50.0% UK vs 59.5% India;Mann-Whitney U- P=0.483) and 16.5% (13.9% UK vs 17.7% India, P=0.529), respectively. Overall, 29.6% had BDD with higher prevalence in the UK women (36.1% UK vs 26.6% India; P=0.208). Participants had higher scores for BAOP (overall: 15.5/48 (13.0-18.0)) with higher scores for UK women (UK: 16 (13.3 - 18.9); vs India: 15 (12.5 - 17.5); P=0.575). The overall scores for FSFI were towards the upper end of the scale (20.4/36 (7.5-25.2)) with no significant difference between the two groups (UK: 23.1 (13.2 - 26.2); vs India: 17.7 (6.9-24.5); P=0.413). Post-survey results further revealed that a proportion of women felt limited information was provided about anxiety (UK: 6/19 (31.6%);vs India: 17/40 (42.5%)), depressive symptoms (UK: 5/19 (26.3%); vs India: 19/40 (47.5%)) or body image concerns UK: 3/19 (15.8%); vs India: 10/40 (25%)) during consultation.
Conclusion: There is a high prevalence of emotional ill-being associated with PCOS both in the UK and India. While it is challenging to encompass all aspects of clinical care during consultation, future work should explore alternate ways to improve screening and management of emotional wellbeing in women with PCOS.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more